H.C. Wainwright analyst Raghuram Selvaraju downgraded Oragenics (NYSE: OGEN) from Buy to Neutral.The analyst comments "On June 1, Ocugen announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE